PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 8, 2026Bioethics

Post‐Trial Responsibilities for Participants Implanted With Neurosurgical Devices: A Qualitative Study

View Full Paper
Ask AI
Bookmark
Share

Authors

NHNathan HigginsACAdrian CarterJGJohn Gardner

Discussion

Loading...

Member takes

Overview

Qualitative study uncovers complex post-trial obligations among neurosurgical trial investigators, highlighting tensions between clinical research ethics and long-term therapeutic care.

Key Points

  • To investigate how clinical trial investigators perceive, interpret, and enact ethical responsibilities toward participants implanted with neurosurgical devices after a trial concludes.
  • Qualitative interview design using semi-structured interviews.
  • Sample included n = 21 investigators actively involved in clinical trials evaluating implantable neurosurgical devices.
  • Investigators reported significant institutional and regulatory pressures that directly shape how they manage participant wellbeing after trial completion.
  • High surgical risks and ongoing device requirements frequently foster participant dependence, blurring boundaries between research integrity and therapeutic care and prompting post-trial commitments beyond standard clinical research practice.

Cite This Study

Higgins et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd82058e84d0ff5b47620https://doi.org/10.1111/bioe.70186
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recommendations on post-trial responsibility in implantable neural device research: a multidisciplinary consensus study2026 · 2 citations
  2. 2Post-trial access to implantable neural devices: an exploratory international survey2024 · 4 citations
  3. 3Continuing trial responsibilities for implantable neural devices2023 · 18 citations
  4. 4<scp>Post‐trial</scp> responsibilities in pragmatic clinical trials: Fulfilling the promise of research to drive <scp>real‐world</scp> change2024 · 2 citations
  5. 5Need for greater post-trial support for clinical trial participants assessing high-risk, irreversible treatments2024 · 10 citations